[Masked arterial hypertension in patients with type2 diabetes mellitus: Prevalence, associated factors and cardiovascular impact].

L'hypertension artérielle masquée chez les diabétiques de type 2 : Prévalence, facteurs associés et retentissement cardiovasculaire.
Diabète type 2 Hypertension artérielle masquée Masked arterial hypertension Type 2 diabetes ambulatory blood pressure measurement diabetic nephropathy diastolic dysfunction dysfonction diastolique mesure ambulatoire de la pression artérielle néphropathie diabétique

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 05 08 2021
accepted: 13 10 2021
pubmed: 19 1 2022
medline: 25 5 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

Masked arterial hypertension (MHTN) is a recently described entity that is associated with the same cardiovascular risk as permanent hypertension. Its prevalence is more frequent in patients with diabetes. The objective of this study is to assess the value of systematic screening for MHTN by 24-hour blood pressure monitoring in a population of type 2 diabetic patients by estimating its prevalence and looking for predictive factors of MHTN in this population. Through a prospective study, we recruited normotensive type 2 diabetics for clinical measurement, in whom we systematically searched for MHTN by performing an ambulatory blood pressure measurement (ABPM). The diagnosis of MHTN is established if: mean daytime BP ≥ 135/85 mmHg and / or, mean nighttime BP ≥ 120/70 mmHg and / or, mean 24 hour BP ≥ 130/80 mmHg. We then compared the two populations of MHTN (G1) and normotensive (G2) on clinical and laboratory parameters and we assessed end-organ damage in order to identify the predictive factors of MHTN. We recruited 53 patients whose mean age was 55.3 ± 8.4 years (range 35-72 years) with a female predominance (53%). The duration of diabetes was on average 8.7 ± 3.9 years with extremes between 2 and 17 years. The average BMI of our patients was 28.2 ± 5.3 Kg/m2. Overweight was found in almost half of our patients (47.2%). Obesity was found in 32.1% of cases. Metabolic syndrome was found in 64.2% of patients. In our study, the prevalence of HTAM in type 2 diabetics was 64%. We also found that MHTN was more often nocturnal (58.5%) and occurred mainly in non-dipper patients. Left ventricular hypertrophy, microalbuminuria and arterial stiffness evidenced by pulse pressure greater than 60mmHg were more common in the MHTN group. For the predictive factors of MHTN, we were able to collect in univariate analysis the following factors: duration of diabetes, fasting blood sugar, weight and microalbuminuria. In multivariate analysis, the predictive factors that emerged in our study are poor glycemic control (HbA1c ≥7%), high BMI and duration of diabetes. MHTN should be sought in diabetics because it allows a better assessment of the cardiovascular risk, in particular by identifying end-organ damage.

Identifiants

pubmed: 35039143
pii: S0003-3928(21)00165-7
doi: 10.1016/j.ancard.2021.10.018
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

136-140

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Faten Hadjkacem (F)

Service d'endocrinologie, Hôpital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Faten Triki (F)

Service de cardiologie, Hopital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Hamdi Frikha (H)

Service d'endocrinologie, Hôpital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie. Electronic address: frikha.hmd@gmail.com.

Salma Charfeddine (S)

Service de cardiologie, Hopital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Khouloud Boujelbene (K)

Service d'endocrinologie, Hôpital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Dorra Ghorbel (D)

Service d'endocrinologie, Hôpital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Samir Kammoun (S)

Service de cardiologie, Hopital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Mohamed Abid (M)

Service d'endocrinologie, Hôpital Hédi Chaker Sfax Tunisie, Faculté de médecine de Sfax, Université de Sfax, Tunisie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH